Manatuck Hill Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,000
Closed -$584K 154
2021
Q4
$584K Buy
+20,000
New +$572K 0.22% 75

Other funds holding CDMO

Manatuck Hill Partners's CDMO Position: Q1 2022 in Review

Manatuck Hill Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 20,000 shares — an estimated $584K sold.

Manatuck Hill Partners first reported a position in CDMO in Q4 2021 and held it in 1 quarter. The position peaked at $584K in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • Manatuck Hill Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Manatuck Hill Partners sold 20,000 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $584K.
  • Manatuck Hill Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Manatuck Hill Partners's Avid Bioservices, Inc. Common Stock position peaked at $584K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Manatuck Hill Partners's 13F filing for Q1 2022, filed 16 May 2022.